Background: Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu. It can be eaten as a sweet or savory food in all ways that rice is used. Due to the presence of high fiber content, it is suggested as a food for diabetic patients in India.
Objective: To evaluate the antihyperglycemic and hypolipidemic potential of S. italica seeds in streptozotocin induced diabetic rats.
Methods: Anti hyperglycemic activity of different doses of S. italica seed aqueous extract (SISAE) was evaluated by oral administration of SISAE in streptozotocin induced diabetic rats and it was compared with that of Glibeclamide, a standard oral hypoglycemic agent. The effect of long-term treatment with 300mgofSISAE/kgb.w./day on blood glucose, glycemic control and serum lipids was evaluated in normal and diabetic rats.
Results: The dose of 300mg of SISAE/kgb.w. produced a significant fall (70%) in blood glucose in diabetic rats after 6h of administration of the extract. None of the doses of the SISAE could produce any change in blood glucose levels of normal rats. After 30 days of treatment with 300mgofSISAE/kgb.w./day there was a significant decrease in fasting blood glucose associated with a significant improvement in glycemic control as evidenced by lower levels of HbA1c in diabetic treated rats when compared to those in untreated diabetic rats The aqueous extract also exhibited significant hypolipidemic effect which is evident from lower levels of triglycerides, total, LDL and VLDL cholesterol and increase in the levels of HDL cholesterol in diabetic treated rats compared to those in diabetic untreated rats. The antihyperglycemic and hypolipidemic activities of the aqueous extract could be due to the presence of alkaloids or glycosides as active principles.
Conclusion: These findings demonstrate that the aqueous extract of S. italica seeds have excellent antihyperglycemic and hypolipidemic activities and thus have great potential as a source for natural health products.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pathophys.2010.08.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Stabilized and Highly Soluble Bezafibrate-Gliclazide Co-Amorphous Binary System.
AAPS PharmSciTech
January 2025
School of Engineering and Sciences, Tecnologico de Monterrey, Campus Monterrey, Ave. Eugenio Garza Sada 2501 Sur, C.P. 64849, Monterrey, N.L., Mexico.
Metabolic syndrome (MS) has a high prevalence, with an estimated one-quarter of the world population affected by this pathological condition. Among the diseases of this syndrome are dysregulation of lipids, hypertension, and insulin resistance. Unfortunately, available drugs in the market used for treating MS, as almost 75% of all drugs, are highly insoluble, presenting a significant demand for strategies to increase their solubility.
View Article and Find Full Text PDFEvaluating the Antidiabetic Activity of Latex in Alloxan-Induced Diabetic Rats and the Development of a Novel Effervescent Granule-Based Delivery System.
ScientificWorldJournal
January 2025
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Sana'a University, Sana'a, Yemen.
Ethnomedicine exhibits potential in developing affordable effective antidiabetic agents. This work aimed to explore the antidiabetic properties of latex extract both in vivo, utilizing alloxan-induced diabetic rats, and in vitro, through -amylase enzyme testing. Additionally, it sought to formulate optimal effervescent granules derived from the extract.
View Article and Find Full Text PDFEffect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.
Obesity (Silver Spring)
February 2025
Novo Nordisk Inc., Plainsboro, New Jersey, USA.
Objective: The objective of this study was to assess antihypertensive and lipid-lowering treatment changes in participants receiving semaglutide 2.4 mg versus placebo across pooled populations from five Semaglutide Treatment Effect in People with Obesity (STEP) trials.
Methods: Efficacy and safety of semaglutide 2.
The Anti-hyperglycemic and Anti-hyperlipidemic Effects of Trigonella foenum-graecum L. Seeds on Fructose-induced Diabetic Wistar Rats.
Plant Foods Hum Nutr
December 2024
Laboratory of Biology and Health, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.
Trigonella foenum-graecum L. (fenugreek) seeds are widely used in the preparation of various meals and in traditional health care to treat various disorders and diseases, especially Diabetes mellitus. This study was conducted to investigate the antihyperglycemic and antihyperlipidemic effects of the fenugreek seed extract on fructose-induced diabetic wistar rats.
View Article and Find Full Text PDFAnti-Hyperlipidemic, Antioxidant, Anti-Inflammatory and Antidiabetic Effect of Brucine Against Streptozotocin-Induced Diabetic Nephropathy in Rats.
J Biochem Mol Toxicol
January 2025
Department of General Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xinjiang Hospital, Urumqi, China.
Among the diabetes-related complications, diabetic nephropathy is the major complication and it leads to end-stage renal failure. In the current investigation, we examined the protection of brucine, an alkaloid extracted from the seeds of Strychnos nux vomica plant widely used in traditional Chinese and Indian medicines against diabetic-induced nephropathy. Male Wistar rats were divided into four groups: control, diabetic rats, diabetic-induced + 40 mg/kg brucine-treated rats, and diabetic-induced + 25 mg/kg metformin-treated rats.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!